Plain-English translation of NCT06445634 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing a surgical approach called gonioscopy-assisted transluminal trabeculotomy (GATT) combined with goniosynechiolysis for people with secondary angle-closure glaucoma. In this condition, scar tissue builds up and blocks the eye's natural drainage system, causing eye pressure to rise dangerously. The surgery aims to help fluid drain better from the eye by creating new pathways and removing scar tissue that's blocking the angle.
Many people with angle-closure glaucoma have scar tissue that prevents fluid from draining properly, and existing treatments haven't controlled their eye pressure. This trial tests whether combining two procedures together might work better than other current treatment options for this specific type of glaucoma.
You likely qualify if…
You likely don't qualify if…
You would receive the surgical procedure at the hospital. The surgeon would use specialized equipment to look inside your eye, remove the scar tissue blocking drainage, and create new pathways for fluid to flow out of your eye. After surgery, you would have follow-up visits to monitor your eye pressure, healing, and how well the procedure worked.
AI-generated summary from trial data · Jun 6, 2026 · Not medical advice
Egypt
Sponsor
Kasr El Aini Hospital
Enrollment target
~23 participants
Started
April 2024
Primary completion
August 2025
This trial's estimated completion date has passed — the record may not be fully up to date.
Last updated on clinicaltrials.gov in June 2024.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Rokaya Radwan
Kasr El Aini Hospital
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.